News and blogs
29 results found.
AI: it’s not all “robot uprisings” - A true force for good in the healthcare space
Read more how blood cancer researcher Professor Daniel Royston is using AI to help improve the diagnosis and treatment of blood cancer.
Our highlights from the 2024 ASH conference
Read more on highlights from the 2024 annual American Society of Haematology (ASH) conference
From despair to hope: The Matthew Wilson Multiple Myeloma Fund
Matthew Wilson establishes the Matthew Wilson Multiple Myeloma Fund (MWMMF) at Blood Cancer UK.
What we can achieve with £1 million
We're proud to announce We’ve invested over £1 million funding five research projects, across five different blood cancers
How we helped Covid booster vaccine research
Discover how Blood Cancer UK played a key part in Covid booster vaccine research for immune compromised patients, helping to create the OCTAVE-DUO study.
Can a blood test detect cancer?
Learn more about a new blood test that looks at cell-free DNA (cfDNA) that could detect cancers earlier.
Five reasons for people with blood cancer to be hopeful about the Covid pandemic
Find out why better treatments and vaccine efficacy should make people with blood cancer more hopeful about the Covid pandemic.
Do people with myeloma have an antibody response to the Covid vaccine?
How can I get involved in blood cancer research?
Find out how you can get involved in blood cancer research to help us beat blood cancer.
Should people with blood cancer get an antibody test?
Read more about what people with blood cancer should know about antibody tests and the Covid vaccine.
How was the coronavirus vaccine created?
Learn how the coronavirus vaccines were made, including information on clinical trials, vaccine approvals and long-term side effects.
The coronavirus vaccine: what you need to know
We explain what we know about the potential vaccines and what they could mean for people with blood cancer.
How does the coronavirus affect people with blood cancer?
Blood Cancer UK are funding vital research that will explore how different types of blood cancer might affect someone’s individual level of risk from coronavirus.
New research hope for those with a rare type of leukaemia
Our research fellow, Dr Marc Mansour and his team, have come to understand more about why some types of T-cell acute lymphoblastic leukaemia (T-ALL) stop responding to chemotherapy, and how we might overcome it in the future.
What causes leukaemia and how can we use this information to better treat it?
How does the immune system recognise and destroy Hodgkin lymphoma?
In Hodgkin lymphoma, the cells which are the root cause of the cancer are hidden within a much larger number of white blood cells. These white blood cells are usually very good at killing cancer cells, but may be unable to kill all of the Hodgkin lymphoma cells. Bloodwise Visiting Fellow Dr Zumla Cader has been investigating why...
Researchers say blood cancer beaten in a few decades
Blood cancer researchers are excited about the future and say the scientific progress made mean blood cancer can be beaten in the next few decades.
How did a weapon of war become a blood cancer treatment?
As we pay tribute to the soldiers of World War I, we look at the surprising link between the battlefields of France and blood cancer research.
Blood cancer documentary gave me hope.
War in the Blood, a new BBC documentary follows two people who received CAR-T therapy, a groundbreaking new treatment for blood cancer, as part of a clinical trial. Kate, our Senior Support Services Manager, reviews the documentary.
How to cope with stress: tips from Bloodwise researchers
For Mental Health Awareness Week, two Bloodwise-funded researchers share things they do to try to maintain mental wellbeing in a stressful environment.